| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2605 |
| Trial ID | NCT04778579 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ARI-0001|Axi-cel|YesCAR-Ta|Axicabtagene Ciloleucel |
| Generation | 2nd |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy |
| Year | 2021 |
| Country | Spain |
| Company sponsor | Sara V. Latorre |
| Other ID(s) | CART19-BE-02 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||